Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.10 (6.667%)
Open: 1.55
High: 1.55
Low: 1.55
Prev. Close: 1.55
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations

Wed, 01st Sep 2021 14:33

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

SDCL Energy Efficiency Income Trust PLC - investment company - Extends and increases revolving credit facility to GBP145 million. The RCF is used by the company for short-term financing of acquisitions. The new expiry date is June 30, 2024. The RCF also includes an uncommitted accordion of a further GBP55 million.

----------

Henry Boot PLC - Sheffield, England-based construction and property development business - Says its property development unit, HBD, has signed a GBP53.8 million funding deal with Oxenwood Real Estate to progress a logistics scheme in Nottingham. "New Horizon is a landmark 28-acre site, which was formerly home to Imperial Tobacco. The deal will see the development of seven industrial units from 30,000 square foot to 145,000 square foot on a speculative basis and is capable of creating up to 1,000 new jobs for the city," company say .

----------

Mattioli Woods PLC - Leicester-based asset manager - Extends long stop date for sellers of Ludlow Wealth Management to September 30 from August 31. In mid-May, agreed to buy Ludlow, a financial planning business in the North West of England with assets under advice of GBP1.6 billion, for up to GBP43.5 million.

----------

Severfield PLC - York, England-based steel company - Says trading in the first five months of the 2022 financial year has "continued to be positive" and is in line with management's expectations. "The group's financial position remains good, albeit the recent steel and other input price rises are impacting working capital in the short term, and the outlook for the year ending March 31, 2022 is unchanged," company adds. Expects profit to have second half bias, with several ongoing contracts expected to deliver higher profits in the second half of the year. Notes September 1 order book in UK and Europe at GBP376 million, a record for company, with GBP291 million to be delivered in next 12 months.

----------

Trifast PLC - Uckfield, England-based industrial fastenings firm - Buys US-based fastenings distributor Falcon Fastening Solutions Inc for USD8.3 million on a cash free-debt free basis, which has been funded through existing cash and financing facilities. Chief Executive Mark Belton says: "The Carolinas region is a strategically important area for us where a number of our global OEMs have facilities. The culture, values and work ethic at Falcon in many ways reflect those of TR. We believe that the combination of Falcon and Trifast's locations, experience, knowledge base and skill sets will open significant opportunities to expand the service and portfolio offering to both existing and new customers on a domestic and international basis We look forward to working together to create a stronger presence for Trifast in North America." Expects deal to be earnings enhancing in the financial year-ending March 31, 2022.

----------

Eckoh PLC - London-based secure payment products provider - Says trading in first four months of financial year, to July 31, in line with market expectations. Notes financial position remains strong.

----------

Velocys PLC - Oxford, England-based fuels technology company - Wins maximum grant of GBP2.4 million from UK Department for Transport (DfT) under the Green Fuels, Green Skies competition, for for Altalto project. The Altalto project is a collaboration between Velocys and British Airways; the proposed plant will convert hundreds of thousands of tonnes per year of residual waste into sustainable fuels, mainly aviation fuel. Chief Executive Henrik Wareborn says: "We are very pleased to have this enhanced level of support from the Department for Transport for the Altalto project. The momentum for sustainable aviation fuel in the UK and around the world is growing, demonstrated here by the recent consultations on the path to net zero aviation and on a SAF mandate. This grant demonstrates that the Altalto project is a key part of the strategy to accelerate a SAF industry in the UK."

----------

Circle Property PLC - London-based buyer, developer and manager of regional office assets in UK - To sell One Castle Park, Bristol to Boultbee LDN Capital Ltd for GBP20 million, which represents 3.9% increase on March 31 valuation of GBP19.3 million. Deal expected to be completed on December 16. "The cash proceeds from the sale will be utilised, in line with previous announcements, to reduce the company's gearing from the current level. The company has a number of assets that have benefited from an active management approach where considerable value has been added following redevelopment, lease restructures or renewals," company says.

----------

Ince Group PLC - legal and professional services firm - Subsidiary James Stocks & Co begins trading as Ince Corporate Finance. The business will continue to be led by Tim Stocks, founder and managing director, who has over 30 years' experience in private practice as a lawyer specialising in corporate finance and securities work. Chief Executive Adrian Biles says: "Since joining the group as a subsidiary last year, Tim and his team have integrated well with our global legal and consulting businesses. The quality of their advice and solutions are second to none and has significantly strengthened our multi-disciplinary offering. Re-branding the business as Ince Corporate Finance will further bolster our brand as we continue to build and grow the business in the coming years."

----------

Longboat Energy PLC - North Sea-focused exploration firm - Completes farm-ins with Equinor, Idemitsu and Spirit for exploration drilling programme on the Norwegian Continental Shelf. Now expects to complete the drilling of four exploration wells in its seven well programme before the end of 2021. Chief Executive Helge Hammer says: "We are pleased that the Farm-Ins have completed and we are now operational, with Longboat about to embark upon the drilling of four wells over the next few months in an extremely busy and exciting time for the company."

----------

Galantas Gold Corp - Northern Ireland-focused gold producer - Shares start trading on the OTCQX Best Market in the US. Chief Executive Mario Stifano says: "The OTCQX listing marks an important milestone for Galantas. Our decision to cross-trade in the US is part of our strategy to grow our international shareholder base and promote greater liquidity as we continue our focus on expanding high-grade gold production and the mineral resources at our Omagh project in Northern Ireland."

----------

MyHealthChecked PLC - Cardiff-based healthcare company and fertility tracking firm - Secures ISO 15189:2012 accreditation across its Covid-19 testing service. Company says this is "a mark of confidence that the service meets internationally recognised gold standards for performance and competence." The accreditation was granted following assessments by the UK Accreditation Service. Chief Executive Penny McCormick says: "We are delighted to now have in place accreditation across our Covid-19 testing service, which is a clear sign to our existing customers and potential new customers that our medical laboratories and operational systems are extremely rigorous and structured around best possible practice within the industry." Yourgene Health PLC gets same accreditation for its Citylabs 1.0 laboratory in Manchester.

----------

Watchstone Group PLC - Eastleigh-based investor in litigation and contingent assets - Urges shareholders not to act on increased Polygon Global Partners LLP offer. "Accordingly, the directors unanimously recommend to shareholders that they should take no action in relation to the final offer and should not sign any document sent to them by Polygon or its advisers," company says. On Tuesday, Polygon increased and final mandatory cash offer for the shares it does not already own in Watchstone. The new offer is worth 38p per share, up 12% from the previous offer of 34p per share, valuing Watchstone at GBP17.5 million. As of Wednesday, Polygon had received acceptances representing 1.4% of Watchstone shares. Polygon already has a 30% stake in Watchstone, the threshold at which it has to make an offer for the remaining shares.

----------

IQ-AI Ltd - Jersey-based medical services and software company - Shares begin trading on the OTCQB Venture Market in the US. Chief Executive Trevor Brown says: "The US is home to some of the world's most influential medical technology investors. By joining OTCQB, we now have an effective platform from which to reach a significantly larger investor audience and we look forward to providing investors in both the UK and the US with regular progress updates at this exciting and pivotal time for the company."

----------

Kazera Global PLC - investment company focused on opportunities in the resources and energy sectors - Makes plan with DJ Drilling, which will lead to the "profitable production" of Tantalum from its mine in Namibia before the end of 2021. Joint Chief Executive Larry Kazera says: "DJ Drilling committing to undertake the work to get the mine into operation as well as their bringing in the necessary equipment has unlocked the current impasse and is a true reflection of their commitment to the project and their belief in its potential. We look forward to a long and fruitful future together."

----------

SulNOx Group PLC - AQSE-listed London-based hydrocarbon fuel emulsification specialist - Starts new large-scale trial of its SulNOxEco fuel conditioner product. "The Stannah group of companies, the UK's largest independent lift business and world renowned stairlift manufacturer, has embarked upon an important trial to reduce emissions from its corporate fleet. Stannah has partnered with SulNOx to trial the SulNOxEco fuel conditioner in 40 vehicles based at its Southwest England & South Wales branch," company explains.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more
10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

Read more
19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which is its subsidiary Imaging Biometrics LLC's therapeutic for the treatment of adult patients with relapsed or refractory glioblastoma.

Read more
5 Dec 2023 11:49

IQ-AI stock rises on positive interim results from glioblastoma trial

(Alliance News) - IQ-AI Ltd on Tuesday reported positive results from Phase 1 of an on-going study for its investigational monotherapy oral gallium maltolate.

Read more
8 Nov 2023 12:04

IQ-AI says Imaging Biometrics submits paediatric rare disease request

(Alliance News) - IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy.

Read more
18 Oct 2023 17:11

IN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer study

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Notes its wholly-owned subsidiary, Imaging Biometrics LLC (IB), has announced the results of a "landmark" study. Says the study represents the first large-scale characterization of the invasive tumour margins of high-grade glioma using multi-regional genomic/transcriptomic sequencing with spatially matched MRI measurements in glioma. High-grade glioma is a deadly brain cancer. Explains that Imaging Biometrics' IB Neuro's dynamic susceptibility contrast magnetic resonance imaging software was central to the study.

Read more
9 Oct 2023 12:09

IN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDA

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Wholly-owned subsidiary Imaging Biometrics LLC is granted an orphan drug designation from the US Food & Drug Administration for gallium maltolate for the treatment of atypical teratoid rhabdoid tumour. Notes this is the second orphan designation granted to gallium maltolate this year.

Read more
8 Sep 2023 10:25

IQ-AI notes vindication of subsidiary's reduced gadolinium approach

(Alliance News) - IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging's MRI-focused IB Neuro.

Read more
18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

Read more
17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

Read more
19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Read more
13 Jul 2023 11:36

IN BRIEF: IQ-AI granted orphan drug designation for Gallium Galtolate

IQ-AI Ltd on Thursday - Jersey-based incubator of software and other tools for the treatment of cancer - IQ-AI subsidiary Imaging Biometrics LLC has been granted an orphan drug designation for Gallium Galtolate for the treatment of paediatric glioblastoma multiforme, or GBM, by the US Food & Drug Administration. Says GBM is the most common and aggressive primary brain tumour in adults and children. Imaging Biometrics' application to the FDA was first submitted in April. In June, two pre-clinical studies showed oral GaM inhibits brain tumour growth in children, and the results were consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin.

Read more
27 Jun 2023 11:47

IN BRIEF: IQ-AI notes Gallium Moltate studies on tumour growth

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin. This follows IB's application for Orphan Drug Designation to the US Food & Drug Administration back in April for the use of GaM in pediatric brain tumours. Notes application is currently under review.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.